UA95958C2 - Antibody that binds to cd22, immunoconjugates and uses therefor - Google Patents
Antibody that binds to cd22, immunoconjugates and uses thereforInfo
- Publication number
- UA95958C2 UA95958C2 UAA200815084A UAA200815084A UA95958C2 UA 95958 C2 UA95958 C2 UA 95958C2 UA A200815084 A UAA200815084 A UA A200815084A UA A200815084 A UAA200815084 A UA A200815084A UA 95958 C2 UA95958 C2 UA 95958C2
- Authority
- UA
- Ukraine
- Prior art keywords
- antibody
- binds
- immunoconjugates
- uses therefor
- immunoconjugate
- Prior art date
Links
- 229940127121 immunoconjugate Drugs 0.000 title abstract 2
- 102100038080 B-cell receptor CD22 Human genes 0.000 abstract 2
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000012472 biological sample Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The invention relates to an antibody that specifically binds to CD22, a polynucleotide encoding the antibody, a vector, a host cell, a process for the preparation of the antibody, a method of detecting the presence of CD22 in a biological sample, an immunoconjugate etc.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80932806P | 2006-05-30 | 2006-05-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA95958C2 true UA95958C2 (en) | 2011-09-26 |
Family
ID=40892057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200815084A UA95958C2 (en) | 2006-05-30 | 2007-05-29 | Antibody that binds to cd22, immunoconjugates and uses therefor |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN101490087B (en) |
| SI (1) | SI2032606T1 (en) |
| UA (1) | UA95958C2 (en) |
| ZA (1) | ZA200809776B (en) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110070227A1 (en) * | 2009-09-18 | 2011-03-24 | Anna-Marie Novotney-Barry | Treatment of Autoimmune and Inflammatory Diseases |
| KR102090849B1 (en) * | 2012-07-04 | 2020-03-19 | 에프. 호프만-라 로슈 아게 | Covalently linked antigen-antibody conjugates |
| EP2869847B1 (en) * | 2012-07-09 | 2017-12-06 | Genentech, Inc. | Immunoconjugates comprising anti-cd79b antibodies |
| PE20150325A1 (en) * | 2012-07-09 | 2015-03-05 | Genentech Inc | IMMUNOCONJUGATES INCLUDING ANTI-CD22 ANTIBODIES AND DERIVATIVES OF NEMORUBICIN. |
| CA2873889A1 (en) * | 2012-07-09 | 2014-01-16 | Genentech, Inc. | Anti-cd22 antibodies and immunoconjugates |
| KR102498405B1 (en) | 2012-10-11 | 2023-02-09 | 다이이찌 산쿄 가부시키가이샤 | Method for producing a glycinamide compound |
| WO2014061277A1 (en) | 2012-10-19 | 2014-04-24 | 第一三共株式会社 | Antibody-drug conjugate produced by binding through linker having hydrophilic structure |
| JP6553515B2 (en) * | 2012-12-20 | 2019-07-31 | メディミューン,エルエルシー | Method for producing immune complex |
| EP2968552B1 (en) * | 2013-03-14 | 2020-03-11 | The Scripps Research Institute | Targeting agent antibody conjugates and uses thereof |
| FR3008408B1 (en) | 2013-07-11 | 2018-03-09 | Mc Saf | NOVEL ANTIBODY-MEDICAMENT CONJUGATES AND THEIR USE IN THERAPY |
| PT3088419T (en) | 2013-12-25 | 2019-01-11 | Daiichi Sankyo Co Ltd | ANTI-TROP2-PHARMACEUTICAL ANTIBODY CONJUGATE |
| CA2928794C (en) | 2014-01-31 | 2019-08-13 | Daiichi Sankyo Company, Limited | Anti-her2 antibody-drug conjugate |
| RU2711640C2 (en) | 2014-04-10 | 2020-01-17 | Дайити Санкио Компани, Лимитед | Anti-her3 antibody-drug conjugate |
| WO2015155976A1 (en) | 2014-04-10 | 2015-10-15 | 第一三共株式会社 | (anti-her2 antibody)-drug conjugate |
| SG11201610624WA (en) * | 2014-06-20 | 2017-01-27 | Bioalliance Cv | Anti-cd22 antibody-drug conjugates and methods of using thereof |
| JP6618539B2 (en) * | 2014-12-17 | 2019-12-11 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Method for enzyme-mediated polypeptide conjugation using sortase |
| KR20170098821A (en) * | 2014-12-17 | 2017-08-30 | 에프. 호프만-라 로슈 아게 | Enzymatic one-pot reaction for double polypeptide conjugation in a single step using sortase |
| CN107922477B (en) | 2015-06-29 | 2022-11-01 | 第一三共株式会社 | Methods for selectively making antibody-drug conjugates |
| CN106467575B (en) * | 2015-08-18 | 2020-07-31 | 四川百利药业有限责任公司 | Cysteine engineered antibody-toxin conjugates |
| TWI660741B (en) * | 2015-11-03 | 2019-06-01 | 財團法人工業技術研究院 | Antibody-drug conjugate (adc) and method for forming the same |
| EP3373937B1 (en) * | 2015-11-09 | 2021-12-22 | R.P. Scherer Technologies, LLC | Anti-cd22 antibody-maytansine conjugates and methods of use thereof |
| KR102537651B1 (en) | 2017-01-17 | 2023-05-26 | 다이이찌 산쿄 가부시키가이샤 | Anti-GPR20 Antibodies and Anti-GPR20 Antibody-Drug Conjugates |
| CN116672463A (en) * | 2017-02-17 | 2023-09-01 | 浙江特瑞思药业股份有限公司 | Preparation method of targeted CD20 antibody coupling drug, antibody coupling drug and application thereof |
| TW202530219A (en) | 2017-05-15 | 2025-08-01 | 日商第一三共股份有限公司 | Method for producing antibody-drug conjugates |
| WO2019044946A1 (en) | 2017-08-31 | 2019-03-07 | 第一三共株式会社 | Novel method for producing antibody-drug conjugate |
| AU2018327171B2 (en) | 2017-08-31 | 2023-03-09 | Daiichi Sankyo Company, Limited | Improved method for producing antibody-drug conjugate |
| CA3079959A1 (en) * | 2017-10-27 | 2018-10-26 | Transfusion Health, Llc | Compositions and methods of making expanded hematopoietic stem cells using derivatives of fluorene |
| AU2018375787B2 (en) * | 2017-11-30 | 2023-02-23 | Ladrx Corporation | Albumin-binding prodrugs of auristatin E derivatives |
| CN108727499B (en) * | 2018-04-24 | 2021-12-31 | 四川百利药业有限责任公司 | Cysteine engineered antibody-toxin conjugates |
| BR112020023373A2 (en) | 2018-05-18 | 2021-02-09 | Daiichi Sankyo Company, Limited | conjugate, composition, and, use of a conjugate or composition |
| TWI846717B (en) | 2018-07-27 | 2024-07-01 | 日商第一三共股份有限公司 | Protein recognizing drug part of antibody-drug conjugate |
| US12220604B2 (en) | 2018-07-31 | 2025-02-11 | Daiichi Sankyo Company, Limited | Treatment of metastatic brain tumor by administration of an antibody-drug conjugate |
| CN109824759A (en) * | 2019-03-08 | 2019-05-31 | 联宁(苏州)生物制药有限公司 | A kind of Preparation Method And Their Intermediate of the drug-linker MC-MMAF for antibody drug conjugates |
| MX2022015695A (en) * | 2020-06-08 | 2023-03-21 | Baili Bio Chengdu Pharmaceutical Co Ltd | Camptothecin drug having high-stability hydrophilic connecting unit and conjugate thereof. |
| CN112924665B (en) * | 2021-02-19 | 2023-10-03 | 山东莱博生物科技有限公司 | Antibody horseradish peroxidase marker and preparation and application thereof |
-
2007
- 2007-05-29 SI SI200731382T patent/SI2032606T1/en unknown
- 2007-05-29 ZA ZA200809776A patent/ZA200809776B/en unknown
- 2007-05-29 CN CN2007800261175A patent/CN101490087B/en not_active Expired - Fee Related
- 2007-05-29 UA UAA200815084A patent/UA95958C2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101490087A (en) | 2009-07-22 |
| SI2032606T1 (en) | 2014-02-28 |
| ZA200809776B (en) | 2010-03-31 |
| CN101490087B (en) | 2013-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA95958C2 (en) | Antibody that binds to cd22, immunoconjugates and uses therefor | |
| UA94628C2 (en) | Humanized monoclonal antibody that binds to steap-1 and use thereof | |
| WO2009126934A3 (en) | Detection and tratment of pancreatic, ovarian and other cancers | |
| PL2326349T3 (en) | Novel reagents and method for conjugating biological molecules | |
| WO2010065568A3 (en) | METHODS AND ASSAYS FOR MEASURING p95 AND/OR p95 IN A SAMPLE AND ANTIBODIES SPECIFIC FOR p95 | |
| MX2009003938A (en) | Antibodies and immunoconjugates and uses therefor. | |
| UA116618C2 (en) | CONSTITUTION-BASED CYSTEINE ANTIBODY AGAINST CD79b | |
| PH12014502054B1 (en) | Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly | |
| WO2006124641A3 (en) | Anti-mesothelin antibodies useful for immunological assays | |
| MY164577A (en) | Antitumor combinations containing antibodies recognizing specifically cd38 and melphalan | |
| TNSN08548A1 (en) | Prlr-specific antibody and uses thereof | |
| TN2011000242A1 (en) | Antitumor combinations containing antibodies recognizing specifically cd38 and cytarabine | |
| WO2011053565A3 (en) | Compositions and methods for detecting a tauopathy | |
| WO2010096674A3 (en) | A+ biomarker assays | |
| WO2009105212A3 (en) | Detection of polyomavirus | |
| UA99292C2 (en) | Antibody which specifically binds to neuropilin-2b (nrp2b) | |
| ZA200711153B (en) | Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase | |
| TW200741203A (en) | Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody | |
| WO2009051741A3 (en) | Methods for processing generic chemical structure representations | |
| WO2008070333A3 (en) | Automated detection of cancer and high grade hyperplasias | |
| WO2009120183A3 (en) | System for the detection of a biological pathogen and use thereof | |
| IL215322A0 (en) | Method for detecting antibody against sith-1 in biological sample | |
| WO2007067984A3 (en) | Neutralizing antibodies against primate psgl-1 and uses therefor | |
| GB201119585D0 (en) | Assay | |
| MX341181B (en) | Method for testing a subject thought to be predisposed to having metastatic cancer using delta133p53beta. |